← Back to front page
Europe · Financial press · Financial Times

Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn

Published by Financial Times · United Kingdom 51 min ago
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn
Financial Times

Detailed summary

Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector

Read the full article on Financial Times Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.ft.com)

Also worth reading